These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1859896)

  • 41. Therapy of acute myelogenous leukemia: results of combination chemotherapy with cytarabine, daunorubicin and 6-mercaptopurine.
    Ko WS; Chen LM; Hwang SH; Chao TY; Wang CC; Kao WY; Lee WC; Hwang WS
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Sep; 48(3):185-9. PubMed ID: 1657335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy of adult acute myeloid leukaemia.
    Suri R; Kueh YK; Han P; Tan YO
    Ann Acad Med Singap; 1990 Mar; 19(2):175-7. PubMed ID: 2346291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia.
    Schiller G; Gajewski J; Nimer S; Territo M; Ho W; Lee M; Champlin R
    Br J Haematol; 1992 Jun; 81(2):170-7. PubMed ID: 1643014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An extreme example of focal bone marrow involvement in acute myeloid leukemia.
    Brierley CK; Morgan EA; Sprague JR; Odejide OO; DeAngelo DJ; Steensma DP
    Am J Hematol; 2013 Apr; 88(4):335-6. PubMed ID: 23115117
    [No Abstract]   [Full Text] [Related]  

  • 45. [Acute myelogenous leukemia in elderly patients].
    Mori M
    Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):192-6. PubMed ID: 10879065
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot].
    Balcar-Boroń A; Nowaczyk-Michalak A; Graduszewska-Czerebiej K
    Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866
    [No Abstract]   [Full Text] [Related]  

  • 47. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
    Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
    J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Marked bone marrow eosinophilia at the time of relapse of acute myeloblastic leukaemia in association with the appearance of translocation t(12;20)(q24;q11).
    Partridge F; Richardson W; Kearns P; Wilcox R; Majumdar G
    Leuk Lymphoma; 1996 Jun; 22(1-2):181-2. PubMed ID: 8724547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
    Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
    Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
    [No Abstract]   [Full Text] [Related]  

  • 50. Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.
    Champlin R; Gajewski J; Nimer S; Vollset S; Landaw E; Winston D; Schiller G; Ho W
    J Clin Oncol; 1990 Jul; 8(7):1199-206. PubMed ID: 1694236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
    Witteveen EO; Verdonck LF; Nieuwenhuis HK; Dekker AW
    Haematol Blood Transfus; 1990; 33():309-13. PubMed ID: 2323635
    [No Abstract]   [Full Text] [Related]  

  • 52. Outpatient administration of liposomal daunorubicin and cytarabine (Vyxeos) in patients with secondary acute myeloid leukemia.
    Kasner MT
    Clin Adv Hematol Oncol; 2019 Nov; 17(11):604-606. PubMed ID: 31851160
    [No Abstract]   [Full Text] [Related]  

  • 53. Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine.
    Wiedower E; Jamy O; Martin MG
    Anticancer Res; 2015 Nov; 35(11):6287-90. PubMed ID: 26504064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Administration schedule of daunorubicin for elderly patients with acute myelogenous leukemia: a single-institute experience.
    Dobashi N; Usui N; Yano S; Yahagi Y; Takei Y; Sugiyama K; Takahara S; Ogasawara Y; Yamaguchi Y; Saito T; Yokoyama H; Aiba K
    Jpn J Clin Oncol; 2011 Jun; 41(6):820-4. PubMed ID: 21415001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine.
    Hwang YY; Tsui P; Leung RY; Kwong YL
    Ann Hematol; 2013 Jan; 92(2):267-8. PubMed ID: 22903510
    [No Abstract]   [Full Text] [Related]  

  • 56. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
    Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study.
    Marty M; Lepage E; Guy H; Bordessoule D; Desablens B; Harousseau JL; Guilhot F; Leverger G; Schaison G; Boiron M
    Haematol Blood Transfus; 1987; 30():50-6. PubMed ID: 3305217
    [No Abstract]   [Full Text] [Related]  

  • 58. Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients.
    Libura M; Giebel S; Piatkowska-Jakubas B; Pawelczyk M; Florek I; Matiakowska K; Jazwiec B; Borg K; Solarska I; Zawada M; Czekalska S; Libura J; Jakobczyk M; Karabin K; Paluszewska M; Calbecka M; Gajkowska-Kulik J; Gadomska G; Kielbinski M; Ejduk A; Kata D; Grosicki S; Wierzbowska A; Kyrcz-Krzemien S; Warzocha K; Kuliczkowski K; Skotnicki A; Holowiecki J; Jedrzejczak WW; Haus O
    Blood; 2016 Jan; 127(3):360-2. PubMed ID: 26567156
    [No Abstract]   [Full Text] [Related]  

  • 59. [Progress of chemotherapy in adult acute leukemia].
    Ohno R
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):431-6. PubMed ID: 7887634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute myelogenous leukemia associated with a mediastinal tumor.
    Chubachi A; Miura I; Takahashi N; Nimura T; Imai H; Miura AB
    Leuk Lymphoma; 1993 Dec; 12(1-2):143-6. PubMed ID: 8161930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.